Subscribe Now

* You will receive the latest news and updates on your favorite celebrities!

Trending News

Adults & T1D

New Promising Treatment Combines CRISPR With Stem Cell Therapy to Reverse Diabetes in Mice 

One of the most common chronic disease in children and adolescents is type 1 diabetes;  studies reveal that more than 40 million individuals are affected worldwide by the condition. In patients with type 1 diabetes, the pancreas no longer produces insulin because the body’s immune system attacks its beta cells for reasons still unknown. Today’s …

Weekly Coronavirus Resources for People with T1D — 5/1/2020 

Your Daily News Roundup We’re all in this together!  Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place.  Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better cope with …

Adults & T1D

Dexcom Launches Crucial Patient Assistance Program As Result of COVID-19 Pandemic 

The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …

Adults & T1D

Boston 25 News – Boston-Based Study Blazing Trail on COVID-19 Connection to Diabetes 

The ongoing outbreak of the novel respiratory disease COVID-19 has become a significant threat to global health and individuals with pre-existing medical conditions. To gain a deeper understanding of how the coronavirus is affecting people with type 1 diabetes, T1D Exchange is leading a first-of-its-kind COVID-19 research surveillance study in partnership with more than 50 …

Adults & T1D

T1D Exchange Announces Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes 

T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.

Eli Lilly Announces Groundbreaking Affordable Insulin Program. 

Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak. Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with …

Challenges & Complications

How People With Diabetes and Others Can Get Early Supplies of Essential Medicine 

As the novel coronavirus COVID-19 continues to spread in the United States, many people are understandably concerned about access to their medications. Health officials and medical professionals working in federal, state and local governments recommend that high-risk individuals with underlying health conditions such as Type 1 Diabetes, stock up on their prescription medications, in addition to practicing basic hygiene and avoiding crowded places.

T1D Exchange Coordinates With Local Authorities to Provide Hand Sanitizer and Medical Supplies 

With the COVID-19 coronavirus continuing to spread and disrupt daily life, supply chains and medical operations, there is an increasing need for access to vital basics such as hand sanitizer. Through an ongoing partnership with MassBio, we were able to answer the call – along with numerous other organizations – as to how we can …

WordPress Theme built by Shufflehound. © 2020 T1D Exchange. All Rights Reserved.